The SNABB ADHD treatment scale-An easy-to-use scale on treatment monitoring in childhood ADHD: A pilot study.

Front Child Adolesc Psychiatry

Child and Adolescent Specialist Centre, Angered Hospital, SV Hospital Group, Gothenburg, Sweden.

Published: April 2023

Introduction: Information from parents and teachers are essential in the treatment monitoring of children with attention deficit hyperactivity disorder (ADHD). Rating scales are infrequently used in the treatment monitoring, and clinicians are signalling logistic barriers in the administration of rating scales in clinical settings. Here, we aimed to try out a new easy-to-use scale to facilitate information sharing between parents, teachers, and medical staff, in the treatment of childhood ADHD.

Methods: We examined the SNABB scale in a clinical sample of 27 child- and adolescent patients with any type of ADHD, in a routine clinical setting. We compared the outcome of the new SNABB scale with the commonly used Swanson, Nolan, and Pelham Teacher and Parent ADHD rating scale-version IV (SNAP-IV).

Results: The SNABB questions concerning ADHD cardinal symptoms hyperactivity and impulsivity were associated with the concurrent SNAP-IV subscale, with moderate to strong correlations. The SNABB inattention question failed all associations with the concurrent SNAP-IV inattention subscale. A secondary finding was that the SNABB mood regulation question correlated with the SNAP-IV ODD-subscale at all three measure points.

Conclusion: Present pilot study brings promising results for the possibility to carry out larger scale studies concerning the psychometric properties of the SNABB scale.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732116PMC
http://dx.doi.org/10.3389/frcha.2023.1114565DOI Listing

Publication Analysis

Top Keywords

treatment monitoring
12
snabb scale
12
easy-to-use scale
8
pilot study
8
parents teachers
8
adhd rating
8
rating scales
8
concurrent snap-iv
8
snabb
7
scale
6

Similar Publications

Alzheimer's disease (AD) is a debilitating neurodegenerative disease that is marked by profound neurovascular dysfunction and significant cell-specific alterations in the brain vasculature. Recent advances in high throughput single-cell transcriptomics technology have enabled the study of the human brain vasculature at an unprecedented depth. Additionally, the understudied niche of cerebrovascular cells, such as endothelial and mural cells, and their subtypes have been scrutinized for understanding cellular and transcriptional heterogeneity in AD.

View Article and Find Full Text PDF

Avascular necrosis in pediatric rheumatic diseases: an Italian retrospective multicentre study.

Ital J Pediatr

January 2025

Pediatric Immuno-Rheumatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Background: Atraumatic avascular necrosis (AVN) is a severe condition that may complicate the course of rheumatic diseases and contribute to long-term damage. However, there is a lack of evidence on this rare event in pediatric rheumatology. The aim of our study was to evaluate the occurrence of avascular necrosis in the context of rheumatologic diseases in Italy and to describe the main demographic and clinical features of AVN patients, with a particular focus on treatment background.

View Article and Find Full Text PDF

Knowledge translation initiatives at the Transitional Pain Service: insights from healthcare provider outreach and patient education.

BMC Health Serv Res

January 2025

Pain Research Unit, Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

Evidence-based treatment of chronic pain requires a multidisciplinary approach grounded in the biopsychosocial model. Implementing this approach within health systems relies on its acceptance by both healthcare providers and patients. While pioneering multidisciplinary pain clinics can serve as a model for implementation, a systematic effort is needed to share knowledge effectively and broadly.

View Article and Find Full Text PDF

Steatohepatitis-induced vascular niche alterations promote melanoma metastasis.

Cancer Metab

January 2025

Department of Dermatology, Venereology and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, Mannheim, 68167, Germany.

Background: In malignant melanoma, liver metastases significantly reduce survival, even despite highly effective new therapies. Given the increase in metabolic liver diseases such as metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), this study investigated the impact of liver sinusoidal endothelial cell (LSEC)-specific alterations in MASLD/MASH on hepatic melanoma metastasis.

Methods: Mice were fed a choline-deficient L-amino acid-defined (CDAA) diet for ten weeks to induce MASH-associated liver fibrosis, or a CDAA diet or a high fat diet (HFD) for shorter periods of time to induce early steatosis-associated alterations.

View Article and Find Full Text PDF

Background: Although impaired cognitive control is common during the acute detoxification phase of substance use disorders (SUD) and is considered a major cause of relapse, it remains unclear after prolonged methadone maintenance treatment (MMT). The aim of the present study was to elucidate cognitive control in individuals with heroin use disorder (HUD) after prolonged MMT and its association with previous relapse.

Methods: A total of 63 HUD subjects (41 subjects with previous relapse and 22 non-relapse subjects, mean MMT duration: 12.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!